Abnormal volume & undervalued
1 Year Price Target: $23.00 for a 180+/-% return
About: Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as...
If you missed the 2x from my previews call:
Then you should know that the stock was hit by a big selloff, even though they beat the consensus analyst revenue estimate in Q4 with sales being higher 24% year over year to $27.1 million.
This might be your 50% upside potential chance.
If you are interested to test some amazing BUY and SELL INDICATORS which give...
Co-Diagnostics Wins Regulatory Approval to Sell COVID-19 Tests in Europe!
Nov 17MT Newswires: Co-Diagnostics (CODX) said it has received regulatory authorization to sell its Logix Smart ABC and SARS-CoV-2 multiplex tests for the diagnosis of COVID-19 in markets that accept CE markings.
The indicators are looking bullish on lower timeframes, which can mean a...
Here we have the CO DIAGNOSTICS INC - Cboe BZX (CODX) chart, which is the stocks now tracking the coronavirus... This thing is showing massive growth.
We can start by looking at the weekly timeframe... This is a complex setup for me, TA here is hard.
CODX (W):
When the chart is looking like the one above, it is hard for me to pinpoint what will happen next......
This could be the next NASDAQ Biotech ready to move in a big way, here's why...
(Nasdaq: CODX) displaying the Holy grail of Bullish signals - a GOLDEN CROSS.
The 50 Day EMA just crossed the 200 Day EMA, which most of you know by now is a bullish signal that indicates a potential breakout is on the Horizon.
Here Is Another Potential "Breakout Catalyst" In Play...
